Chapter 21

Z00–Z99: Factors Influencing Health Status and Contact with Health Services

Factors Influencing Health Status and Contact with Health Services diagnostic classification updated for 2026.

Internal Codes
  • Z79.4

    Long term (current) use of insulin

  • Z79.5

    Long term (current) use of steroids

  • Z79.51

    Long term (current) use of inhaled steroids

  • Z79.52

    Long term (current) use of systemic steroids

  • Z79.6

    Long term (current) use of immunomodulators and immunosuppressants

  • Z79.60

    Long term (current) use of unspecified immunomodulators and immunosuppressants

  • Z79.61

    Long term (current) use of immunomodulator

  • Z79.62

    Long term (current) use of immunosuppressant

  • Z79.620

    Long term (current) use of immunosuppressive biologic

  • Z79.621

    Long term (current) use of calcineurin inhibitor

  • Z79.622

    Long term (current) use of Janus kinase inhibitor

  • Z79.623

    Long term (current) use of mammalian target of rapamycin (mTOR) inhibitor

  • Z79.624

    Long term (current) use of inhibitors of nucleotide synthesis

  • Z79.63

    Long term (current) use of chemotherapeutic agent

  • Z79.630

    Long term (current) use of alkylating agent

  • Z79.631

    Long term (current) use of antimetabolite agent

  • Z79.632

    Long term (current) use of antitumor antibiotic

  • Z79.633

    Long term (current) use of mitotic inhibitor

  • Z79.634

    Long term (current) use of topoisomerase inhibitor

  • Z79.64

    Long term (current) use of myelosuppressive agent

  • Z79.69

    Long term (current) use of other immunomodulators and immunosuppressants

  • Z79.8

    Other long term (current) drug therapy

  • Z79.81

    Long term (current) use of agents affecting estrogen receptors and estrogen levels

  • Z79.810

    Long term (current) use of selective estrogen receptor modulators (SERMs)

  • Z79.811

    Long term (current) use of aromatase inhibitors

  • Z79.818

    Long term (current) use of other agents affecting estrogen receptors and estrogen levels

  • Z79.82

    Long term (current) use of aspirin

  • Z79.83

    Long term (current) use of bisphosphonates

  • Z79.84

    Long term (current) use of oral hypoglycemic drugs

  • Z79.85

    Long-term (current) use of injectable non-insulin antidiabetic drugs

  • Z79.89

    Other long term (current) drug therapy

  • Z79.890

    Hormone replacement therapy

  • Z79.891

    Long term (current) use of opiate analgesic

  • Z79.899

    Other long term (current) drug therapy

  • Z80

    Family history of primary malignant neoplasm

  • Z80.0

    Family history of malignant neoplasm of digestive organs

  • Z80.1

    Family history of malignant neoplasm of trachea, bronchus and lung

  • Z80.2

    Family history of malignant neoplasm of other respiratory and intrathoracic organs

  • Z80.3

    Family history of malignant neoplasm of breast

  • Z80.4

    Family history of malignant neoplasm of genital organs

  • Z80.41

    Family history of malignant neoplasm of ovary

  • Z80.42

    Family history of malignant neoplasm of prostate

  • Z80.43

    Family history of malignant neoplasm of testis

  • Z80.44

    Family history of malignant neoplasm of fallopian tube(s)

  • Z80.49

    Family history of malignant neoplasm of other genital organs

  • Z80.5

    Family history of malignant neoplasm of urinary tract

  • Z80.51

    Family history of malignant neoplasm of kidney

  • Z80.52

    Family history of malignant neoplasm of bladder

  • Z80.59

    Family history of malignant neoplasm of other urinary tract organ

  • Z80.6

    Family history of leukemia

PreviousPage 24 of 37Next